Axa’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-103,079
Closed -$21.9M 1565
2014
Q4
$21.9M Sell
103,079
-27,924
-21% -$5.55M 0.09% 248
2014
Q3
$23.3M Sell
131,003
-7,327
-5% -$1.22M 0.1% 232
2014
Q2
$23.4M Sell
138,330
-25,334
-15% -$3.94M 0.1% 236
2014
Q1
$20.3M Buy
163,664
+10,067
+7% +$1.23M 0.09% 249
2013
Q4
$17.1M Buy
153,597
+21,769
+17% +$2.08M 0.08% 273
2013
Q3
$11.9M Sell
131,828
-349,529
-73% -$31.4M 0.06% 331
2013
Q2
$40.5M Buy
+481,357
New +$49.9M 0.22% 124

Other funds holding AGN

Axa's AGN Position: Q1 2015 in Review

Axa sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 103,079 shares — an estimated $21.9M sold.

Axa first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $40.5M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Axa reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Axa sold 103,079 Allergan Inc shares in Q1 2015, an estimated $21.9M.
  • Axa first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Axa's Allergan Inc position peaked at $40.5M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Axa's 13F filing for Q1 2015, filed 13 May 2015.